Worried about paying for your cancer care? Discover steps you can take to find help and ease the financial distress you feel.

Open enrollment is the time of year that you can make changes to your health insurance coverage, usually through the Health Insurance Marketplace. Our financial specialists answer key questions to help you prepare for 2025 open enrollment.

If you’re a Medicare beneficiary, learn what changes you can make in your coverage during open enrollment. Our financial navigators explain your options.

As you make decisions about your cancer treatment, it can be helpful to understand what prior authorization is and how it can impact your care. Sometimes, prior authorization programs can be barriers to getting needed treatments. Keep reading to learn more, including what to do if your health insurance company denies a prior authorization request from your healthcare provider.

Have you ever arrived at a laboratory or pharmacy with your doctor's order for lab work or a prescription, only to be denied the test or your prescribed medication? Each insurance plan has different benefits and coverage guidelines. Benefit managers determine these guidelines. Keep reading to learn how laboratory and pharmacy benefit managers can impact your insurance benefits and coverage.

If your insurance provider denies a claim for medical services you’ve received, you have the right to file an appeal. The process of filing an appeal can seem daunting. But it is both your right and in your best interest to appeal a denied claim that you and your healthcare team deem important for your health. Keep reading for step-by-step guidance and tools to help you through the process.

High-deductible health plans (HDHPs) are an increasingly popular type of health plan, especially for employer-sponsored plans. This blog explains how these health plans work and certain risks they can pose for enrollees — particularly for those with a chronic health condition or serious illness, such as cancer.

On January 1, 2022, the No Surprises Act went into effect. This is a new law that protects patients from unexpected or “surprise” medical bills. Keep reading to learn about these new protections for patients.

Clinical trials are a promising avenue for expanding treatment options and extending survival for people with cancer. However, out-of-pocket costs associated with trial participation and gaps in insurance coverage create barriers for many cancer patients. The CLINICAL TREATMENT Act guarantees coverage of the routine care costs of clinical trial participation for Medicaid enrollees with life-threatening conditions, like cancer.

Medicare Part D is a voluntary outpatient prescription drug benefit to assist people in affording their prescription medications. Part D benefits are provided through private health insurance plans and approved by the federal government. Participants in Part D are able to choose between supplementing their traditional Medicare with a stand-alone prescription drug plan or a Medicare Advantage prescription drug plan that is part of and includes other aspects of Medicare. In November, 2018 the Centers for Medicare & Medicaid Services (CMS) proposed a new rule for Part D that would have changed the special coverage protections for medications included in the six protected classes.